Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumors.
Multiple types of oncolytic viruses are currently under investigation in clinical trials. To optimize therapeutic outcomes it is believed that the plethora of different tumor types will require a diversity of different virus types. Sendai virus (SeV), a murine parainfluenza virus, displays a broad h...
Saved in:
| Main Authors: | Martina Zimmermann, Sorin Armeanu-Ebinger, Sascha Bossow, Johanna Lampe, Irina Smirnow, Andrea Schenk, Sebastian Lange, Thomas S Weiss, Wolfgang Neubert, Ulrich M Lauer, Michael Bitzer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0090508&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Sendai Framework and Satellite Security
by: Jessie Hamill-Stewart
Published: (2025-01-01) -
Crisis Response: Sendai Framework’s Hits and Misses
by: Luavut Zahid
Published: (2025-01-01) -
The Peace Imperative for the Sendai Framework for Disaster Risk Reduction
by: Laura E. R. Peters
Published: (2024-12-01) -
Oncolytic virotherapy and the current approaches in veterinary medicine
by: Bengu Bilgic, et al.
Published: (2022-01-01) -
The Anticipated Effects of Sendai Framework Action Plan in Integrated Disaster Management
by: İrfan Macit
Published: (2019-01-01)